11 stories from 6 sources
Supporting Articles
Paramount CEO David Ellison secured support for the Warner Bros. Discovery deal by making commitments intended to address Hollywood's concerns, including theatrical distribution. Skeptics question whether those protections will hold once the five-year agreement expires.
2:01 AMCNBC
Paramount Skydance says its proposed $111 billion merger with Warner Bros. Discovery may close within weeks, but the timing remains uncertain. The company is preparing to issue warrants to Paramount shareholders on Oct. 5 if the transaction proceeds under its current timetable.
5:46 PMVariety
A coalition opposing the Paramount Skydance and Warner Bros. Discovery merger has filed an amicus brief urging a court to reject Paramount’s settlement with state governments. The groups argue that the settlement should not clear the way for the proposed combination.
5:49 AMVarietyBASF has approached Evonik about a takeover that would value the chemicals group at roughly €12bn. The deal would mark a major step in consolidating Europe’s fragmented chemicals industry.
12:22 PMFinancial TimesAirbus has offered to sell assets to address competition concerns over its proposed space merger with Leonardo and Thales. The concessions are intended to win approval from the European Commission.
9:24 AMFinancial TimesSummary
Paramount CEO David Ellison secured support for the Warner Bros. Discovery deal by making commitments intended to address Hollywood's concerns, including theatrical distribution. Skeptics question whether those protections will hold once the five-year agreement expires.
The antitrust settlement converts immediate industry safeguards into time-limited promises. Filmmakers, theaters, and other distributors
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The deal's cultural and competitive protections may depend less on the closing terms than on what happens when their expiration date arrives.
Summary
Paramount Skydance says its proposed $111 billion merger with Warner Bros. Discovery may close within weeks, but the timing remains uncertain. The company is preparing to issue warrants to Paramount shareholders on Oct. 5 if the transaction proceeds under its current timetable.
Paramount is moving ahead with merger-related mechanics without treating regulatory and closing conditions as resolved.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The planned warrant issuance shows the deal has entered its final procedural phase, but the uncertain closing date keeps execution risk high for both companies' investors.
Summary
A coalition opposing the Paramount Skydance and Warner Bros. Discovery merger has filed an amicus brief urging a court to reject Paramount’s settlement with state governments. The groups argue that the settlement should not clear the way for the proposed combination.
The filing adds another challenge to a deal already facing public and regulatory opposition, even
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The opposition keeps legal uncertainty at the center of the merger and could weaken Paramount’s path to closing.
Summary
BASF has approached Evonik about a takeover that would value the chemicals group at roughly €12bn. The deal would mark a major step in consolidating Europe’s fragmented chemicals industry.
A potential BASF-Evonik combination would bring substantial capacity and product overlap under one owner, increasing
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The approach could reset the scale of Europe’s chemicals industry and trigger a wider race to consolidate.
Summary
Airbus has offered to sell assets to address competition concerns over its proposed space merger with Leonardo and Thales. The concessions are intended to win approval from the European Commission.
Airbus is trading parts of the combined business for a clearer path to closing, signaling
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The concessions show that regulatory approval, not industrial logic alone, will determine the structure of Europe’s space consolidation.
A curated list of other prominent stories from this day.
Cineplex could attract sale offers worth roughly half the value implied by a pre-pandemic 2019 bid, according to an analyst. The estimate reflects the weaker economics facing the movie theater chain after Covid-19 disrupted attendance and industry finances.
9:51 AMBloomberg MarketsNew investors have acquired a controlling interest in PayComplete, a provider of cash automation software, devices, and services. The transaction also supplies the company with significant new capital for growth.
9:23 AMFinextraGordon Brothers is seeking repayment of a £30 million shareholder loan from bidders for Poundland, which it acquired for less than £1. The loan was inherited from the retailer's previous owner.
4:36 AMFinancial TimesSystematic Growth is planning a sale of Wellma Group AB, the Stockholm-based maker of health supplements, according to people familiar with the matter. The potential transaction could value the company at about €1 billion.
2:47 AMBloomberg Markets
Royal Caribbean Group plans to acquire a 50% equity interest in Sandals and Beaches Resorts for approximately $3 billion, subject to approvals and closing conditions. The companies expect the transaction to close in early 2027 and say it will deepen connections between cruise and resort tourism in the Caribbean.
1:08 AMBreaking Travel NewsPharmaceutical companies are pursuing a wave of increasingly complex mergers, while competition concerns and patent disputes create additional legal obstacles. The deals reflect pressure to secure valuable drug assets and strengthen market positions.
12:00 AMFinancial TimesSummary
Cineplex could attract sale offers worth roughly half the value implied by a pre-pandemic 2019 bid, according to an analyst. The estimate reflects the weaker economics facing the movie theater chain after Covid-19 disrupted attendance and industry finances.
The key shift is a sharp reset in Cineplex's potential valuation, with a future sale
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case shows how pandemic-era damage continues to reduce exit values for businesses built around consumer foot traffic.
Summary
New investors have acquired a controlling interest in PayComplete, a provider of cash automation software, devices, and services. The transaction also supplies the company with significant new capital for growth.
The ownership change gives PayComplete funding to expand while shifting strategic control to its new
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Investor backing signals continued value in modernizing cash operations even as digital payments reduce some forms of cash usage.
Summary
Gordon Brothers is seeking repayment of a £30 million shareholder loan from bidders for Poundland, which it acquired for less than £1. The loan was inherited from the retailer's previous owner.
The £30 million claim raises the effective cost of acquiring Poundland and could reduce proceeds
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The inherited loan could complicate Poundland's sale and lower the value bidders place on the business.
Summary
Systematic Growth is planning a sale of Wellma Group AB, the Stockholm-based maker of health supplements, according to people familiar with the matter. The potential transaction could value the company at about €1 billion.
A potential €1 billion sale would put Wellma among the more valuable assets in the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The sale could reset valuation benchmarks for health-supplement companies and accelerate consolidation in the category.
Summary
Royal Caribbean Group plans to acquire a 50% equity interest in Sandals and Beaches Resorts for approximately $3 billion, subject to approvals and closing conditions. The companies expect the transaction to close in early 2027 and say it will deepen connections between cruise and resort tourism in the Caribbean.
The proposed deal would link Royal Caribbean’s cruise customer base and distribution system with Sandals’
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The transaction could reshape how Caribbean travel is packaged and distributed across cruise and resort businesses.
Summary
Pharmaceutical companies are pursuing a wave of increasingly complex mergers, while competition concerns and patent disputes create additional legal obstacles. The deals reflect pressure to secure valuable drug assets and strengthen market positions.
The deal surge is colliding with tougher scrutiny over market concentration and intellectual property rights.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The mergers could reshape drug competition, but regulatory and patent challenges may delay deals or reduce their value.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!